Facebook
Messenger
Twitter
LinkedIn
Email
Print
Mayo Researchers Explore Genetics Behind COVID-19 Outcomes
Share this:
Some patients with COVID-19 experience severe complications, such as organ damage, shortness of breath, neurological impairment and chronic fatigue. A team of researchers within Mayo Clinic Center for Individualized Medicine is contributing to the global effort of using advanced genetic sequencing to find out which genes influence disease outcomes.
“Our findings will be crucial in treating and caring for COVID-19 survivors, as well as to try to prevent lingering complications in newly infected people,” says Konstantinos Lazaridis, M.D., the Everett J. and Jane M. Hauck associate director of Mayo Clinic Center for Individualized Medicine.
Dr. Lazaridis and his team are building a library of genomic sequencing data of consented patients who tested positive for COVID-19. Learn more about Dr. Lazaridis' work at the Center for Individualized Medicine.
Make a gift now to help transform the future of health care today.
Sean C. Dowdy, M.D., is the chief value officer at Mayo Clinic and the Robert D. and Patricia E. Kern Associate Dean for Practice Transformation. He shares how quality serves as the foundation of Mayo Clinic’s approach, extending beyond patient care to include staff experience, health equity, and the cost of care.
Charlotte Markle's kidney transplant at Mayo Clinic was over 57 years ago on March 2, 1966, making her Mayo's longest-surviving transplant recipient. Marking its 60th anniversary this month, the Mayo Clinic Transplant Center is the largest integrated transplant center in the U.S.
Despite a record year for organ donation last year in the U.S., an estimated 17 people die every day waiting for a transplant. Yet Mayo Clinic transplant experts are optimistic that solutions to some of the biggest transplant challenges are on the horizon, thanks to new technology, research and innovations.